Healthcare provider profile · identity verified

Dahlia Riad, MD

Internal Medicine · ABINGTON, MA · NPI 1396736708

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	293	101
Amlodipine Besylate	Amlodipine Besylate	287	79
Levothyroxine Sodium	Levothyroxine Sodium	230	70
Lisinopril	Lisinopril	218	72
Gabapentin	Gabapentin	168	45
Simvastatin	Simvastatin	164	51
Losartan Potassium	Losartan Potassium	143	43
Omeprazole	Omeprazole	142	49
Pantoprazole Sodium	Pantoprazole Sodium	126	38
Metoprolol Succinate	Metoprolol Succinate	109	42
Rosuvastatin Calcium	Rosuvastatin Calcium	102	30
Hydrochlorothiazide	Hydrochlorothiazide	94	35
Lorazepam	Lorazepam	92	36
Atenolol	Atenolol	76	28
Alprazolam	Alprazolam	68	23
Furosemide	Furosemide	68	22
Citalopram Hbr	Citalopram Hydrobromide	65	23
Escitalopram Oxalate	Escitalopram Oxalate	65	25
Albuterol Sulfate Hfa	Albuterol Sulfate	63	31
Allopurinol	Allopurinol	62	14
Metformin Hcl	Metformin Hcl	62	24
Metformin Hcl Er	Metformin Hcl	62	17
Metoprolol Tartrate	Metoprolol Tartrate	58	16
Clonazepam	Clonazepam	56	14
Trazodone Hcl	Trazodone Hcl	55	21
Zolpidem Tartrate	Zolpidem Tartrate	52	17
Bupropion Hcl Sr	Bupropion Hcl	49	20
Oxycodone Hcl	Oxycodone Hcl	49	13
Sertraline Hcl	Sertraline Hcl	46	17
Eliquis	Apixaban	44	11
Montelukast Sodium	Montelukast Sodium	42	13
Ezetimibe	Ezetimibe	41	12
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Alendronate Sodium	Alendronate Sodium	38	14
Ozempic	Semaglutide	38	suppressed
Glimepiride	Glimepiride	36	11
Lovastatin	Lovastatin	34	suppressed
Tramadol Hcl	Tramadol Hcl	34	14
Tamsulosin Hcl	Tamsulosin Hcl	33	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	32	suppressed
Potassium Chloride	Potassium Chloride	31	suppressed
Jardiance	Empagliflozin	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	11
Nystatin	Nystatin	28	14
Fluticasone Propionate	Fluticasone Propionate	27	11
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Carvedilol	Carvedilol	25	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	22	suppressed
Bupropion Hcl	Bupropion Hcl	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Famotidine	Famotidine	20	suppressed
Meloxicam	Meloxicam	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Glipizide	Glipizide	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Ibuprofen	Ibuprofen	14	11
Valacyclovir	Valacyclovir Hcl	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Prednisone	Prednisone	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Clopidogrel	Clopidogrel Bisulfate	12	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Calcitriol	Calcitriol	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error